Genomic information can provide valuable insights into the prognosis of cancer patients. Certain genetic alterations are associated with more aggressive forms of cancer and poorer outcomes, while others may indicate a better prognosis. For instance, the presence of EGFR mutations in non-small cell lung cancer is often associated with a better response to EGFR inhibitors.
